Original Research

Published on 29 Aug 2024

TGF-β1 overexpression in severe COVID-19 survivors and its implications for early-phase fibrotic abnormalities and long-term functional impairment

in Cytokines and Soluble Mediators in Immunity

Enrique Alfaro
Raquel Casitas
Elena Díaz-García
Sara García-Tovar
Raúl Galera
María Torres-Vargas
María Fernández-Velilla
Cristina López-Fernández
José M. Añón
Manuel Quintana-Díaz

Frontiers in Immunology

doi 10.3389/fimmu.2024.1401015

960 views

Review

Published on 19 Aug 2024

Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential

in Cytokines and Soluble Mediators in Immunity

Carmen Mazzuca
Laura Vitiello
Silvia Travaglini
Fatima Maurizi
Panaiotis Finamore
Simona Santangelo
Amelia Rigon
Marta Vadacca
Silvia Angeletti
Simone Scarlata

Frontiers in Immunology

doi 10.3389/fimmu.2024.1443297

1,819 views

Original Research

Published on 15 Aug 2024

IL-2 and TCR stimulation induce expression and secretion of IL-32β by human T cells

in Cytokines and Soluble Mediators in Immunity

Franziska Christine Sanna
Iva Benešová
Philip Pervan
Adriana Krenz
Alexander Wurzel
Robert Lohmayer
Jasmin Mühlbauer
Amélie Wöllner
Nina Köhl
Ayse Nur Menevse

Frontiers in Immunology

doi 10.3389/fimmu.2024.1437224

1,265 views

Opinion

Published on 14 Aug 2024

Tumor-produced immune regulatory factors as a therapeutic target in cancer treatment

in Cytokines and Soluble Mediators in Immunity

Vladimir Rogovskii

Frontiers in Immunology

doi 10.3389/fimmu.2024.1416458

1,188 views

Original Research

Published on 12 Aug 2024

The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells

in Cytokines and Soluble Mediators in Immunity

Remo Poto
Leonardo Cristinziano
Gjada Criscuolo
Caterina Strisciuglio
Francesco Palestra
Gianluca Lagnese
Antonio Di Salvatore
Gianni Marone
Giuseppe Spadaro
Stefania Loffredo

Frontiers in Immunology

doi 10.3389/fimmu.2024.1443704

1,950 views

Original Research

Published on 02 Aug 2024

Protection of stromal cell-derived factor-1 SDF-1/CXCL12 against proteases yields improved skin wound healing

in Cytokines and Soluble Mediators in Immunity

Rafaela Vaz Sousa Pereira
Mostafa EzEldeen
Estefania Ugarte-Berzal
Jennifer Vandooren
Erik Martens
Mieke Gouwy
Eva Ganseman
Jo Van Damme
Patrick Matthys
Jan Jeroen Vranckx

Frontiers in Immunology

doi 10.3389/fimmu.2024.1359497

1,116 views

Review

Published on 01 Aug 2024

Mast cell stabilizers: from pathogenic roles to targeting therapies

in Cytokines and Soluble Mediators in Immunity

Mengda Cao
Yao Gao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1418897

3,596 views
1 citation

Correction

Published on 30 Jul 2024

Corrigendum: Modulation of natural killer cell exhaustion in the lungs: the key components from lung microenvironment and lung tumor microenvironment

in Cytokines and Soluble Mediators in Immunity

Hongxia Zhang
Jian Wang
Fengqi Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1467723

544 views

Original Research

Published on 25 Jul 2024

Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in mice

in Cytokines and Soluble Mediators in Immunity

Arnaud Huard
Emiliana Rodriguez
Dominique Talabot-Ayer
Andreas Weigert
Gaby Palmer

Frontiers in Immunology

doi 10.3389/fimmu.2024.1387921

1,273 views

Review

Published on 24 Jul 2024

IL-2 based cancer immunotherapies: an evolving paradigm

in Cytokines and Soluble Mediators in Immunity

Sushama Rokade
Anita Mehta Damani
Martin Oft
Jan Emmerich

Frontiers in Immunology

doi 10.3389/fimmu.2024.1433989

5,326 views
1 citation

Original Research

Published on 19 Jul 2024

Femoral nailing associated with bone marrow emboli in pigs induced a specific increase in blood IL-6 and broad inflammatory responses in the heart and lungs

in Cytokines and Soluble Mediators in Immunity

Steinar Kristiansen
Benjamin Stage Storm
Åse Eeg Emblem
Renathe Henriksen Grønli
Kristin Pettersen
Jonas Hilmo
Anders Hagen Jarmund
Martin Leth-Olsen
Siri Ann Nyrnes
Bent Aksel Nilsen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1396800

1,245 views

Original Research

Published on 18 Jul 2024

The causal role of circulating inflammatory markers in osteoporosis: a bidirectional Mendelian randomized study

in Cytokines and Soluble Mediators in Immunity

Qiu Dong
Jiayang Wu
Huaguo Zhang
Liangping Luo
Wenrui Wu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1412298

2,172 views

Original Research

Published on 15 Jul 2024

Dissecting the mediating role of cytokines in the interaction between immune traits and sepsis: insights from comprehensive mendelian randomization

in Cytokines and Soluble Mediators in Immunity

Xiangtao Zheng
Yihui Wang
Yuming Wang
Xiaofeng Wang
Lei Pei
Shanzhi Zhao
Fangchen Gong
Ranran Li
Huan Liu
Wenbin Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1417716

2,266 views

Original Research

Published on 11 Jul 2024

Exploring causal correlations between circulating cytokines and atopic dermatitis: a bidirectional two-sample Mendelian randomization study

in Cytokines and Soluble Mediators in Immunity

Zhenquan Xuan
Xuanyi Chen
Weinan Zhou
Yihang Shen
Zhe Sun
Hui Zhang
Zhirong Yao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1367958

2,359 views

Review

Published on 28 Jun 2024

Bidirectional regulation mechanism of TRPM2 channel: role in oxidative stress, inflammation and ischemia-reperfusion injury

in Cytokines and Soluble Mediators in Immunity

Peng Huang
Chaoyi Qu
Zhijian Rao
Dongzhe Wu
Jiexiu Zhao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1391355

2,397 views
2 citations

Review

Published on 24 Jun 2024

The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions

in Cytokines and Soluble Mediators in Immunity

Irina Kerkis
Álvaro Prieto da Silva
Rodrigo Pinheiro Araldi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1400533

2,885 views
2 citations

Navigation group

Articles

TGF-β1 overexpression in severe COVID-19 survivors and its implications for early-phase fibrotic abnormalities and long-term functional impairment

Immunological and homeostatic pathways of alpha -1 antitrypsin: a new therapeutic potential

IL-2 and TCR stimulation induce expression and secretion of IL-32β by human T cells

Tumor-produced immune regulatory factors as a therapeutic target in cancer treatment

The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells

Protection of stromal cell-derived factor-1 SDF-1/CXCL12 against proteases yields improved skin wound healing

Mast cell stabilizers: from pathogenic roles to targeting therapies

Corrigendum: Modulation of natural killer cell exhaustion in the lungs: the key components from lung microenvironment and lung tumor microenvironment

Interleukin-38 overexpression in keratinocytes limits desquamation but does not affect the global severity of imiquimod-induced skin inflammation in mice

IL-2 based cancer immunotherapies: an evolving paradigm

Femoral nailing associated with bone marrow emboli in pigs induced a specific increase in blood IL-6 and broad inflammatory responses in the heart and lungs

The causal role of circulating inflammatory markers in osteoporosis: a bidirectional Mendelian randomized study

Dissecting the mediating role of cytokines in the interaction between immune traits and sepsis: insights from comprehensive mendelian randomization

Exploring causal correlations between circulating cytokines and atopic dermatitis: a bidirectional two-sample Mendelian randomization study

Bidirectional regulation mechanism of TRPM2 channel: role in oxidative stress, inflammation and ischemia-reperfusion injury

The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions